12
Participants
Start Date
November 12, 2021
Primary Completion Date
January 12, 2022
Study Completion Date
January 12, 2022
PF-07321332/ritonavir
Single oral dose of PF-07321332 300 mg (2 × 150 mg tablets)/ritonavir 100 mg under fed or fasted conditions at 0 hour on Day 1
Ritonavir
Single oral dose of ritonavir 100 mg at -12 hours prior to PF-07321332/ritonavir dosing, and ritonavir 100 mg will be dosed at 12 hours after PF-07321332/ritonavir dosing.
New Haven Clinical Research Unit, New Haven
Lead Sponsor
Pfizer
INDUSTRY